Randomized study of two doses of oral valacyclovir in immunocompromised patients with uncomplicated herpes zoster

Trial Profile

Randomized study of two doses of oral valacyclovir in immunocompromised patients with uncomplicated herpes zoster

Completed
Phase of Trial: Phase II

Latest Information Update: 01 May 2008

At a glance

  • Drugs Valaciclovir (Primary)
  • Indications Herpes zoster
  • Focus Therapeutic Use
  • Most Recent Events

    • 03 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top